Skip to main content

 Scientific publications

PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.

Authors : Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Lett
Volume : 469
Pages : 142-150

Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.

Authors : Bregni G, Akin Telli T, Camera S, Deleporte A, Moretti L, Bali AM, Liberale G, Holbrechts S, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Treat Rev
Volume : 83
Pages : 101948

New therapeutic targets in pancreatic cancer.

Authors : Lai E, Puzzoni M, Ziranu P, Pretta A, Impera V, Mariani S, Liscia N, Soro P, Musio F, Persano M, Donisi C, Tolu S, Balconi F, Pireddu A, Demurtas L, Pusceddu V, Camera S, Sclafani F, Scartozzi M
Year : 2019
Journal : Cancer Treat Rev
Volume : 81
Pages : 101926

Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.

Authors : Bregni G, Akin Telli T, Camera S, Baratelli C, Shaza L, Deleporte A, Moretti L, Bali MA, Liberale G, Hendlisz A, Sclafani F
Year : 2019
Journal : Cancer Treat Rev
Volume : 82
Pages : 101930

Editorial: Adjuvant chemotherapy for rectal cancer: playing the devil's advocate.

Authors : Sclafani F, Hendlisz A
Year : 2019
Journal : Curr Opin Oncol
Volume : 31
Pages : 336-338

MEK and PD-L1 inhibition in colorectal cancer: a burning blaze turning into a flash in the pan.

Authors : Sclafani F
Year : 2019
Journal : Lancet Oncol
Volume : 20
Pages : 752-753